View Item 

Show simple item record

Comparison of CD23 staining patterns in Merkel cell carcinoma and non-cutaneous small cell carcinoma

dc.contributor.authorCarvalho, Jason Cen_US
dc.contributor.authorFullen, Douglas R.en_US
dc.contributor.authorLowe, Lorien_US
dc.contributor.authorSu, Lyndon D.en_US
dc.contributor.authorMa, Lingleien_US
dc.date.accessioned2010-06-01T19:44:27Z
dc.date.available2010-06-01T19:44:27Z
dc.date.issued2009-02en_US
dc.identifier.citationCarvalho, Jason; Fullen, Douglas; Lowe, Lori; Su, Lyndon; Ma, Linglei (2009). "Comparison of CD23 staining patterns in Merkel cell carcinoma and non-cutaneous small cell carcinoma." Journal of Cutaneous Pathology 36(2): 206-210. <http://hdl.handle.net/2027.42/72874>en_US
dc.identifier.issn0303-6987en_US
dc.identifier.issn1600-0560en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/72874
dc.identifier.urihttp://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=18616759&dopt=citationen_US
dc.format.extent820386 bytes
dc.format.extent3109 bytes
dc.format.mimetypeapplication/pdf
dc.format.mimetypetext/plain
dc.publisherBlackwell Publishing Ltden_US
dc.rights© 2008 Blackwell Munksgaarden_US
dc.titleComparison of CD23 staining patterns in Merkel cell carcinoma and non-cutaneous small cell carcinomaen_US
dc.typeArticleen_US
dc.subject.hlbsecondlevelDermatologyen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.contributor.affiliationumDepartment of Dermatology, University of Michigan Medical Center, Ann Arbor, MI, USAen_US
dc.contributor.affiliationotherDepartment of Pathologyen_US
dc.identifier.pmid18616759en_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/72874/1/j.1600-0560.2008.00999.x.pdf
dc.identifier.doi10.1111/j.1600-0560.2008.00999.xen_US
dc.identifier.sourceJournal of Cutaneous Pathologyen_US
dc.identifier.citedreferenceConrad DH. Fc epsilon RII/CD23: the low affinity receptor for IgE. Annu Rev Immunol 1990; 8: 623.en_US
dc.identifier.citedreferenceMossalayi MD, Ouaaz F, Arock M, Merle Beral H, Debre P. The role of soluble CD23 on normal and leukaemic myeloid precursor cells. Res Immunol 1992; 143: 439.en_US
dc.identifier.citedreferenceFournier S, Rubio M, Delespesse G, Sarfati M. Role for low-affinity receptor for IgE (CD23) in normal and leukemic B-cell proliferation. Blood 1994; 84: 1881.en_US
dc.identifier.citedreferenceCarvalho J, Fullen D, Lowe L, Su L, Ma L. The expression of CD23 in cutaneous non-lymphoid neoplasms. J Cutan Pathol 2007; 34: 693.en_US
dc.identifier.citedreferenceKaiserlian D, Lachaux A, Grosjean I, Graber P, Bonnefoy JY. Intestinal epithelial cells express the CD23/Fc epsilon RII molecule: enhanced expression in enteropathies. Immunology 1993; 80: 90.en_US
dc.identifier.citedreferencePoulsen M. Merkel-cell carcinoma of the skin. Lancet Oncol 2004; 5: 593.en_US
dc.identifier.citedreferenceGupta SG, Wang LC, Penas PF, Gellenthin M, Lee SJ, Nghiem P. Sentinel lymph node biopsy for evaluation and treatment of patients with Merkel cell carcinoma: the Dana-Farber experience and meta-analysis of the literature. Arch Dermatol 2006; 142: 685.en_US
dc.identifier.citedreferenceMoll R, Lowe A, Laufer J, Franke WW. Cytokeratin 20 in human carcinomas. A new histodiagnostic marker detected by monoclonal antibodies. Am J Pathol 1992; 140: 427.en_US
dc.identifier.citedreferenceChan JK, Suster S, Wenig BM, Tsang WY, Chan JB, Lau AL. Cytokeratin 20 immunoreactivity distinguishes Merkel cell (primary cutaneous neuroendocrine) carcinomas and salivary gland small cell carcinomas from small cell carcinomas of various sites. Am J Surg Pathol 1997; 21: 226.en_US
dc.identifier.citedreferenceSu LD, Lowe L, Bradford CR, Yahanda AI, Johnson TM, Sondak VK. Immunostaining for cytokeratin 20 improves detection of micrometastatic Merkel cell carcinoma in sentinel lymph nodes. J Am Acad Dermatol 2002; 46: 661.en_US
dc.identifier.citedreferenceBobos M, Hytiroglou P, Kostopoulos I, Karkavelas G, Papadimitriou CS. Immunohistochemical distinction between merkel cell carcinoma and small cell carcinoma of the lung. Am J Dermatopathol 2006; 28: 99.en_US
dc.identifier.citedreferenceOrdonez NG. Value of thyroid transcription factor-1 immunostaining in distinguishing small cell lung carcinomas from other small cell carcinomas. Am J Surg Pathol 2000; 24: 1217.en_US
dc.identifier.citedreferenceHanly AJ, Elgart GW, Jorda M, Smith J, Nadji M. Analysis of thyroid transcription factor-1 and cytokeratin 20 separates merkel cell carcinoma from small cell carcinoma of lung. J Cutan Pathol 2000; 27: 118.en_US
dc.identifier.citedreferenceMcNiff JM, Cowper SE, Lazova R, Subtil A, Glusac EJ. CD56 staining in Merkel cell carcinoma and natural killer-cell lymphoma: magic bullet, diagnostic pitfall, or both? J Cutan Pathol 2005; 32: 541.en_US
dc.identifier.citedreferenceSu LD, Fullen DR, Lowe L, Uherova P, Schnitzer B, Valdez R. CD117 (KIT receptor) expression in Merkel cell carcinoma. Am J Dermatopathol 2002; 24: 289.en_US
dc.identifier.citedreferenceDong HY, Liu W, Cohen P, Mahle CE, Zhang W. B-cell specific activation protein encoded by the PAX-5 gene is commonly expressed in merkel cell carcinoma and small cell carcinomas. Am J Surg Pathol 2005; 29: 687.en_US
dc.identifier.citedreferenceGarcia-Caballero T, Pintos E, Gallego R, et al. MOC-31/Ep-CAM immunoreactivity in Merkel cells and Merkel cell carcinomas. Histopathology 2003; 43: 480.en_US
dc.identifier.citedreferenceLiu Y, Mangini J, Saad R, et al. Diagnostic value of microtubule-associated protein-2 in Merkel cell carcinoma. Appl Immunohistochem Mol Morphol 2003; 11: 326.en_US
dc.identifier.citedreferenceHan AC, Soler AP, Tang CK, Knudsen KA, Salazar H. Nuclear localization of E-cadherin expression in Merkel cell carcinoma. Arch Pathol Lab Med 2000; 124: 1147.en_US
dc.identifier.citedreferenceCai YC, Banner B, Glickman J, Odze RD. Cytokeratin 7 and 20 and thyroid transcription factor 1 can help distinguish pulmonary from gastrointestinal carcinoid and pancreatic endocrine tumors. Hum Pathol 2001; 32: 1087.en_US
dc.identifier.citedreferenceFolpe AL, Gown AM, Lamps LW, et al. Thyroid transcription factor-1: immunohistochemical evaluation in pulmonary neuroendocrine tumors. Mod Pathol 1999; 12: 5.en_US
dc.identifier.citedreferenceWick MR. Immunohistology of neuroendocrine and neuroectodermal tumors. Semin Diagn Pathol 2000; 17: 194.en_US
dc.identifier.citedreferenceByrd-Gloster AL, Khoor A, Glass LF, et al. Differential expression of thyroid transcription factor 1 in small cell lung carcinoma and Merkel cell tumor. Hum Pathol 2000; 31: 58.en_US
dc.identifier.citedreferenceFernandez-Figueras MT, Puig L, Musulen E, et al. Prognostic significance of p27Kip1, p45Skp2 and Ki67 expression profiles in Merkel cell carcinoma, extracutaneous small cell carcinoma, and cutaneous squamous cell carcinoma. Histopathology 2005; 46: 614.en_US
dc.identifier.citedreferenceTachibana T. The Merkel cell: recent findings and unresolved problems. Arch Histol Cytol 1995; 58: 379.en_US
dc.identifier.citedreferenceLeech SN, Kolar AJ, Barrett PD, Sinclair SA, Leonard N. Merkel cell carcinoma can be distinguished from metastatic small cell carcinoma using antibodies to cytokeratin 20 and thyroid transcription factor 1. J Clin Pathol 2001; 54: 727.en_US
dc.identifier.citedreferenceTischler AS. Small cell carcinoma of the lung: cellular origin and relationship to other neoplasms. Semin Oncol 1978; 5: 244.en_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
j.1600-0560.2008.00999.x.pdf
Size:
801.1KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.